| pubmed-article:2428301 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0014080 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0001407 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0001443 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0022230 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0023556 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:2428301 | lifeskim:mentions | umls-concept:C0279023 | lld:lifeskim |
| pubmed-article:2428301 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2428301 | pubmed:dateCreated | 1986-10-6 | lld:pubmed |
| pubmed-article:2428301 | pubmed:abstractText | The antiviral action of different human interferons against encephalomyocarditis virus in HeLa cell cultures was analyzed. Cell treatment with levamisole (200 micrograms/ml), methisoprinol (1 mg/ml), or adenine or adenosine (33 or 100 micrograms/ml, respectively) potentiated the anti-encephalomyocarditis virus activity of human interferon by 8- to 32-fold. A higher level of potentiation (256-fold) was achieved either by combined treatments with levamisole plus methisoprinol or by treatment with one of these compounds plus adenine or adenosine. | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2428301 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2428301 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2428301 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:2428301 | pubmed:issn | 0066-4804 | lld:pubmed |
| pubmed-article:2428301 | pubmed:author | pubmed-author:Pérez-ArandaA... | lld:pubmed |
| pubmed-article:2428301 | pubmed:author | pubmed-author:MuñozAA | lld:pubmed |
| pubmed-article:2428301 | pubmed:author | pubmed-author:GarcíaR ARA | lld:pubmed |
| pubmed-article:2428301 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2428301 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:2428301 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2428301 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2428301 | pubmed:pagination | 192-5 | lld:pubmed |
| pubmed-article:2428301 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:meshHeading | pubmed-meshheading:2428301-... | lld:pubmed |
| pubmed-article:2428301 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:2428301 | pubmed:articleTitle | Potentiation by levamisole, methisoprinol, and adenine or adenosine of the inhibitory activity of human interferon against encephalomyocarditis virus. | lld:pubmed |
| pubmed-article:2428301 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2428301 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2428301 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2428301 | lld:pubmed |
